Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
about
External beam radiation dose escalation for high grade gliomaExternal beam radiation dose escalation for high grade gliomaThe evolving roles and controversies of radiotherapy in the treatment of glioblastomaRadiation and concomitant chemotherapy for patients with glioblastoma multiformeMetabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro studyMagnetic resonance perfusion imaging in neuro-oncology.Present and potential future issues in glioblastoma treatment.Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma.Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastomaGliomas in adults.Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.Improved survival time trends for glioblastoma using the SEER 17 population-based registries.Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma MultiformeA Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.External irradiation models for intracranial 9L glioma studies.Gliosarcoma: a study of four cases.Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaFlow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation.Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 casesHypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiformeIntegrated analysis of mismatch repair system in malignant astrocytomas.Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomasIdentification of novel radiosensitizers in a high-throughput, cell-based screen for DSB repair inhibitors.Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structureDifferentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative AssessmentMR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain TumorsRadiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC-ι activity in vitro.Canadian recommendations for the treatment of glioblastoma multiforme.RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab
P2860
Q24186922-A3D8636A-F37A-4491-A41B-BD076CCA6D03Q26470382-6432193A-FB8B-4C04-9789-38DE0C475EB6Q26746622-B54860D1-1CFC-40A7-946E-13F60624C8DEQ26827957-B97717D1-98C4-4E7C-AE18-1A13C548010AQ28286868-CADC796C-B280-4EB7-A2D7-29E1D0378C53Q30479156-52A985DF-0027-48DD-9E5B-C7C13FAB4DF0Q31043603-36E971A2-C063-4505-8EAF-FD681DAC4D14Q33372533-33C2BD93-CE0E-40C9-80B2-77D826A59EBBQ33416917-F1806551-0DD5-485E-AC05-71DE45215AFFQ33428049-354F1075-C36B-4253-9FB6-4CC9838C5F2DQ33598949-B63FDD80-5AF0-424A-95A7-D7D719640655Q33642194-C9933861-4127-4843-9180-D1DE907A0CE3Q33708309-1E993009-2D3A-4942-A735-3C29E344A8BFQ33760539-AB3AA7F1-8128-4D39-9403-BF5EB273CD56Q33779136-FFB82946-8680-4A9C-B378-A5366AADF29FQ33819663-61A4CB60-0994-4EF3-A8D3-C757252AD804Q33828439-607C3997-FBEF-48C8-9C6D-CC9387268A36Q33832441-C6F1B951-7E7E-42F6-8D9A-146D9C3BC531Q33913465-F610643D-4732-47A8-B242-E5CEBAA4AF5FQ33992432-7A5ADD51-7CAD-4AF4-A514-827CF604A57CQ34132971-12BABBCC-FD8E-456B-BD2D-4C6A01D43E1FQ34295064-687B3A92-6EDB-433D-8077-1D01E2B61EDFQ34353421-0BAF7B11-BBC7-4271-B87A-B0E5BCD758D7Q34364913-75FB0C05-C15D-4A96-AE87-E0DAC79B55E8Q34584754-4DF16B94-9237-466F-BD22-C034C8DFAF72Q34721575-071A95A3-F44F-4ED7-874D-1482903E8FCAQ34722872-0BC940AD-5DB6-495F-B2D3-79224D3B1EF9Q34986417-D8F8ABF0-4A35-4CF4-929B-A13E83AA2DE4Q35000971-AB0C58AD-2470-4811-9860-3FB1438EBC31Q35133423-A26778EF-5CD2-4AAC-B3A1-D10B9018075BQ35171890-B0B1A009-C965-4C15-AC41-0950663E38C9Q35523975-52D0B8CA-7060-486E-9E9B-3AE3AC3ECBC9Q35575434-AF18812E-99B8-42CD-BE6C-4442CB69E638Q35587625-2B4E0962-C7A6-472C-982E-733032CDC2B5Q35689330-7D2A371F-8684-4858-9823-AC8C167F9964Q35760314-47D35312-3255-4161-83F7-C2F20B3D1A71Q35804036-D51AD8B7-E776-4426-ACE4-EC472671D752Q35855352-83E002C1-592B-43A5-8280-215E268541C5Q36127451-7320AA6F-A705-4242-BF4C-81489AC08375Q36285551-0E753DE0-709D-4818-B59D-9A0989D9A1AA
P2860
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@ast
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@en
type
label
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@ast
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@en
prefLabel
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@ast
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@en
P2093
P1476
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.
@en
P2093
Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group
Gregory Cairncross
Lisa Zuraw
P304
P356
10.1016/S0167-8140(02)00078-6
P577
2002-09-01T00:00:00Z